Document is current
Any future updates will be listed below
-
Authors
Gordon, Evan M. https://orcid.org/0000-0002-2276-5237
Chauvin, Roselyne J. https://orcid.org/0000-0001-5786-4705
Van, Andrew N. https://orcid.org/0000-0002-8787-0943
Rajesh, Aishwarya
Nielsen, Ashley
Newbold, Dillan J.
Lynch, Charles J.
Seider, Nicole A.
Krimmel, Samuel R.
Scheidter, Kristen M.
Monk, Julia
Miller, Ryland L. https://orcid.org/0000-0002-9607-9491
Metoki, Athanasia
Montez, David F. https://orcid.org/0000-0003-1672-8218
Zheng, Annie https://orcid.org/0000-0002-8047-9458
Elbau, Immanuel
Madison, Thomas https://orcid.org/0000-0003-3030-6580
Nishino, Tomoyuki
Myers, Michael J.
Kaplan, Sydney
Badke D’Andrea, Carolina
Demeter, Damion V. https://orcid.org/0000-0003-1931-3587
Feigelis, Matthew
Ramirez, Julian S. B.
Xu, Ting https://orcid.org/0000-0002-0065-3832
Barch, Deanna M. https://orcid.org/0000-0003-1693-8506
Smyser, Christopher D. https://orcid.org/0000-0002-4716-5190
Rogers, Cynthia E. https://orcid.org/0000-0001-6251-8436
Zimmermann, Jan https://orcid.org/0000-0003-3345-6074
Botteron, Kelly N.
Pruett, John R.
Willie, Jon T.
Brunner, Peter
Shimony, Joshua S.
Kay, Benjamin P. https://orcid.org/0000-0003-3628-8029
Marek, Scott https://orcid.org/0000-0003-0032-9052
Norris, Scott A.
Gratton, Caterina
Sylvester, Chad M. https://orcid.org/0000-0003-2154-0826
Power, Jonathan D.
Liston, Conor https://orcid.org/0000-0002-1639-5401
Greene, Deanna J. https://orcid.org/0000-0002-0739-7771
Roland, Jarod L. https://orcid.org/0000-0002-1312-8826
Petersen, Steven E.
Raichle, Marcus E.
Laumann, Timothy O.
Fair, Damien A. https://orcid.org/0000-0001-8602-393X
Dosenbach, Nico U. F. https://orcid.org/0000-0002-6876-7078
- License Information
-
More Information
Article History
Received: 2 November 2022
Accepted: 16 March 2023
First Online: 19 April 2023
Competing interests
: D.A.F., N.U.F.D. and N.A.S. have a financial interest in Turing Medical Inc. and may benefit financially if the company is successful in marketing FIRMM motion monitoring software products. A.N.V., D.A.F. and N.U.F.D. may receive royalty income based on FIRMM technology developed at Washington University School of Medicine and Oregon Health and Sciences University and licensed to Turing Medical Inc. D.A.F. and N.U.F.D. are co-founders of Turing Medical Inc. These potential conflicts of interest have been reviewed and are managed by Washington University School of Medicine, Oregon Health and Sciences University and the University of Minnesota. N.A.S. is now an employee of Turing Medical Inc. C.M.S receives research support from Sage Therapeutics. C.L. is listed as an inventor for Cornell University patent applications on neuroimaging biomarkers for depression that are pending or in preparation. C.L. has served as a scientific advisor or consultant to Compass Pathways PLC, Delix Therapeutics, Magnus Medical and Brainify.AI. The other authors declare no competing interests.
